957 resultados para Volatile signature
Resumo:
PURPOSE: Conventional staging methods are inadequate to identify patients with stage II colon cancer (CC) who are at high risk of recurrence after surgery with curative intent. ColDx is a gene expression, microarray-based assay shown to be independently prognostic for recurrence-free interval (RFI) and overall survival in CC. The objective of this study was to further validate ColDx using formalin-fixed, paraffin-embedded specimens collected as part of the Alliance phase III trial, C9581.
PATIENTS AND METHODS: C9581 evaluated edrecolomab versus observation in patients with stage II CC and reported no survival benefit. Under an initial case-cohort sampling design, a randomly selected subcohort (RS) comprised 514 patients from 901 eligible patients with available tissue. Forty-nine additional patients with recurrence events were included in the analysis. Final analysis comprised 393 patients: 360 RS (58 events) and 33 non-RS events. Risk status was determined for each patient by ColDx. The Self-Prentice method was used to test the association between the resulting ColDx risk score and RFI adjusting for standard prognostic variables.
RESULTS: Fifty-five percent of patients (216 of 393) were classified as high risk. After adjustment for prognostic variables that included mismatch repair (MMR) deficiency, ColDx high-risk patients exhibited significantly worse RFI (multivariable hazard ratio, 2.13; 95% CI, 1.3 to 3.5; P < .01). Age and MMR status were marginally significant. RFI at 5 years for patients classified as high risk was 82% (95% CI, 79% to 85%), compared with 91% (95% CI, 89% to 93%) for patients classified as low risk.
CONCLUSION: ColDx is associated with RFI in the C9581 subsample in the presence of other prognostic factors, including MMR deficiency. ColDx could be incorporated with the traditional clinical markers of risk to refine patient prognosis.
Resumo:
Purpose: Prompted by the extensive biases in the immunoglobulin (IG) gene repertoire of splenic marginal-zone lymphoma (SMZL), supporting antigen selection in SMZL ontogeny, we sought to investigate whether antigen involvement is also relevant post-transformation.
Experimental Design: We conducted a large-scale subcloning study of the IG rearrangements of 40 SMZL cases aimed at assessing intraclonal diversification (ID) due to ongoing somatic hypermutation (SHM).
Results: ID was identified in 17 of 21 (81%) rearrangements using the immunoglobulin heavy variable (IGHV)1-2*04 gene versus 8 of 19 (40%) rearrangements utilizing other IGHV genes (P= 0.001). ID was also evident in most analyzed IG light chain gene rearrangements, albeit was more limited compared with IG heavy chains. Identical sequence changes were shared by subclones from different patients utilizing the IGHV1-2*04 gene, confirming restricted ongoing SHM profiles. Non-IGHV1-2*04 cases displayed both a lower number of ongoing SHMs and a lack of shared mutations (per group of cases utilizing the same IGHV gene).
Conclusions: These findings support ongoing antigen involvement in a sizable portion of SMZL and further argue that IGHV1-2*04 SMZL may represent a distinct molecular subtype of the disease.
Resumo:
PURPOSE: Myeloma is a clonal malignancy of plasma cells. Poor-prognosis risk is currently identified by clinical and cytogenetic features. However, these indicators do not capture all prognostic information. Gene expression analysis can be used to identify poor-prognosis patients and this can be improved by combination with information about DNA-level changes. EXPERIMENTAL DESIGN: Using single nucleotide polymorphism-based gene mapping in combination with global gene expression analysis, we have identified homozygous deletions in genes and networks that are relevant to myeloma pathogenesis and outcome. RESULTS: We identified 170 genes with homozygous deletions and corresponding loss of expression. Deletion within the "cell death" network was overrepresented and cases with these deletions had impaired overall survival. From further analysis of these events, we have generated an expression-based signature associated with shorter survival in 258 patients and confirmed this signature in data from two independent groups totaling 800 patients. We defined a gene expression signature of 97 cell death genes that reflects prognosis and confirmed this in two independent data sets. CONCLUSIONS: We developed a simple 6-gene expression signature from the 97-gene signature that can be used to identify poor-prognosis myeloma in the clinical environment. This signature could form the basis of future trials aimed at improving the outcome of poor-prognosis myeloma.
Resumo:
A novel retrodirective array (RDA) architecture is proposed which utilises a special case spectral signature embedded within the data payload as pilot signals. With the help of a pair of phase-locked-loop (PLL) based phase conjugators (PCs) the RDA’s response to other unwanted and/or unfriendly interrogating signals can be disabled, leading to enhanced secrecy performance directly in the wireless physical layer. The effectiveness of the proposed RDA system is experimentally demonstrated.
Resumo:
Programa de doctorado: Sistemas Inteligentes y Aplicaciones Numéricas en Ingeniería
Resumo:
Resources created at the University of Southampton for the module Remote Sensing for Earth Observation
Resumo:
We provide theory and evidence to complement Choi's [RFS, 2013] important new insights on the returns to equity in `value' firms. We show that higher future earnings growth ameliorates the value-reducing effect of leverage and, because the market for earnings is incomplete, reduces the earnings-risk sensitivity of the default option. Ceteris paribus, a levered firm with low (high) earnings growth is more sensitive to the first (second) of these effects thus generating higher (lower) expected returns. We demonstrate this by modeling equity as an Asian-style call option on net earnings and find significant empirical support for our hypotheses.
Resumo:
Lo scopo di questo lavoro di tesi è stato quello di studiare l’efficacia e l’applicabilità dello strumento HERACLES II Flash Gas Chromatography Electronic Nose mediante l’analisi di un set molto ampio di campioni di oli d’oliva vergini reperiti presso un concorso nazionale. Nello specifico, mediante elaborazioni di statistica multivariata dei dati, è stata valutata sia la capacità discriminante del metodo per campioni caratterizzati da un diverso profilo sensoriale, sia la correlazione esistente tra l’intensità delle sensazioni percepite per via sensoriale ed i dati ottenuti mediante l’analisi strumentale. La valutazione delle caratteristiche sensoriali dei campioni è stata realizzata in occasione dello stesso concorso da parte di un gruppo di giudici esperti e secondo le modalità stabilite dai regolamenti comunitari. Ogni campione è stato valutato da almeno 8 assaggiatori che hanno determinato l’intensità di caratteristiche olfattive (eventuali difetti, fruttato e note secondarie positive) e gustative (amaro e piccante). La determinazione dei composti volatili, invece, è stata condotta mediante lo strumento HERACLES II Electronic Nose (AlphaMOS), dotato di due colonne cromatografiche caratterizzate da diversa polarità (MXT-5 con fase stazionaria apolare e MXT-WAX con fase stazionaria polare), ciascuna collegata ad un rivelatore di tipo FID. L’elaborazione multivariata dei dati è stata realizzata mediante il software in dotazione con lo strumento.
Resumo:
Un moyen permettant d'identifier expérimentalement les phases du gaz d'électrons bidimensionnel de la bicouche de graphène en empilement bernal au remplissage $\nu = 3$ est recherché lorsque le biais électrique entre les couches est varié. À ce remplissage, si on se concentre aux basses énergies, il est possible de ne s'intéresser qu'aux deux niveaux de Landau composant le niveau $N=0$ qui sont de même spin et de même vallée, mais d'orbitale différente. Puisque la texture du pseudospin orbital de ce système change selon la phase, il est attendu que le couplage avec le champ électrique de la lumière devrait changer. La dispersion des modes collectifs de chaque phase est calculée dans l'approximation GRPA (generalized random-phase approximation) dans le domaine en biais où chacune domine respectivement. L'absorption optique pour des polarisations linéaires en direction x et en direction y ainsi que pour des polarisations circulaires gauche et droite est calculée. La rotation de Faraday et l'effet Kerr sont également calculés. Des différences entre les phases sont remarquées au niveaux de la fréquence des photons qui sont absorbés, de l'amplitude de l'absorption et de la rotation de la polarisation ainsi que la sensibilité à certains types de polarisation. L'effet des modes collectifs dans les phases considérées est cependant moindre que celui qui est prédit dans un calcul qui ne tient pas compte de l'interaction de Coulomb.
Resumo:
We give a relativistic spin network model for quantum gravity based on the Lorentz group and its q-deformation, the Quantum Lorentz Algebra. We propose a combinatorial model for the path integral given by an integral over suitable representations of this algebra. This generalises the state sum models for the case of the four-dimensional rotation group previously studied in gr-qc/9709028. As a technical tool, formulae for the evaluation of relativistic spin networks for the Lorentz group are developed, with some simple examples which show that the evaluation is finite in interesting cases. We conjecture that the `10J' symbol needed in our model has a finite value.
Resumo:
An 85-year-old male was hospitalized because of deterioration of his general condition and infection of the tracheostoma. He had had laryngectomy, bilateral neck dissection and radiation therapy for a laryngeal carcinoma 5 years earlier. Despite a good recovery, he could not get up because of a new onset of postural symptoms (dizziness, lightheadedness, collapse). Late onset of baroreflex failure and autonomic nervous system failure were diagnosed. Volatility of blood pressure (supine hypertension, upright hypotension) was treated with NaCl supplement during the day and a short-acting antihypertensive (clonidine) at night. With this regimen, the patient could walk without support.